Clinical Trials
10 trialsNCT03820817 2026-05-26
Rifaximin in Patients With Monoclonal Gammopathy
Emory University
Phase 1 Completed
NCT05804032 2026-02-18
Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma
University of Heidelberg Medical Center
Phase 3 Completed
NCT01186224 2025-03-17
PHANTASTIC
University of Liverpool
Phase NA Completed
NCT06559579 2024-08-19
GammaClinik
University Hospital, Brest
Completed
NCT02556931 2022-11-03
Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00048412 2020-01-18
Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H
Baylor College of Medicine
Phase 1/2 Completed
NCT01002755 2019-05-07
Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02033928 2018-02-28
Comprehensive Frailty Assessment
Ohio State University Comprehensive Cancer Center
Completed
NCT01543100 2014-01-06
PACMoG
Rennes University Hospital
Phase NA Completed
NCT01755000 2013-09-02
Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings
Washington University School of Medicine
Phase NA Completed